Professor Duncan Richards
Climax Professor of Clinical Therapeutics and Director of Oxford Clinical Trials Research Unit, University of Oxford
Academic and expert in early drug development
Professor Duncan Richards is a leader in clinical therapeutics and drug development. As the Climax Professor of Clinical Therapeutics and Director of Oxford Clinical Trials Research Unit, he advances new treatments from early-phase clinical trials into clinical practice.
With a strong foundation in medicine from the University of Oxford and extensive experience at GlaxoSmithKline (GSK), Professor Richards is highly regarded for his contributions to early drug development. His active participation on various research committees reflects his dedication to improving patient outcomes through innovative therapies.